Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,017
Closed -$213K 92
2026
Q1
$213K Hold
1,017
0.13% 83
2025
Q4
$289K Buy
+1,017
New +$318K 0.17% 70
2025
Q2
Sell
-8,192
Closed -$2.06M 66
2025
Q1
$2.06M Buy
8,192
+182
+2% +$49.3K 1.8% 21
2024
Q4
$2.09M Buy
+8,010
New +$2.02M 1.88% 19

Other funds holding PODD

SharpePoint's PODD Position: Q2 2026 in Review

SharpePoint sold out of Insulet (PODD) in Q2 2026, closing a stake of 1,017 shares — an estimated $213K sold.

SharpePoint first reported a position in PODD in Q4 2024 and held it in 4 quarters. The position peaked at $2.09M in Q4 2024. 730 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • SharpePoint reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
  • SharpePoint sold 1,017 Insulet shares in Q2 2026, an estimated $213K.
  • SharpePoint first reported a position in Insulet in Q4 2024 and held it in 4 quarters.
  • SharpePoint's Insulet position peaked at $2.09M in Q4 2024.
  • 730 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on SharpePoint's 13F filing for Q2 2026, filed 29 Jul 2026.